CLASS ACTION UPDATE for CC, QUAD and REZI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / December 2, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine ... Read More...

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="NEW YORK, NY / ACCESSWIRE / December 2, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.” data-reactid=”11″>NEW YORK, NY / ACCESSWIRE / December 2, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

The Chemours Company (NYSE:CC)

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="CC Lawsuit on behalf of: investors who purchased February 16, 2017 – August 1, 2019
Lead Plaintiff Deadline: December 9, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/the-chemours-company-loss-form?prid=4694&wire=1” data-reactid=”13″>CC Lawsuit on behalf of: investors who purchased February 16, 2017 – August 1, 2019
Lead Plaintiff Deadline: December 9, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/the-chemours-company-loss-form?prid=4694&wire=1

According to the filed complaint, during the class period, The Chemours Company made materially false and/or misleading statements and/or failed to disclose that: (1) Chemours had not appropriately accounted and accrued reserves for its environmental liabilities; (2) the possibility of costs exceeding accrued amounts was greater than the Company had represented to a point that could be material; (3) the Company’s policies, standards and procedures were not properly designed to prevent unreasonable risk of harm to people and the environment (4) Chemours’ handling, manufacture, use, and disposal of hazardous substances was not in accordance with applicable environmental laws and regulations; and (5) as a result of these misrepresentations, Chemours shares traded at artificially inflated prices.

Quad/Graphics, Inc. (NYSE:QUAD)

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="QUAD Lawsuit on behalf of: investors who purchased February 21, 2018 – October 29, 2019
Lead Plaintiff Deadline: January 6, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/quad-graphics-inc-loss-form?prid=4694&wire=1” data-reactid=”16″>QUAD Lawsuit on behalf of: investors who purchased February 21, 2018 – October 29, 2019
Lead Plaintiff Deadline: January 6, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/quad-graphics-inc-loss-form?prid=4694&wire=1

According to the filed complaint, during the class period, Quad/Graphics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s book business in United States was underperforming; (2) as a result, the Company was likely to divest its book business; (3) the Company was unreasonably vulnerable to decreases in market prices; (4) to remain financially flexible while market prices decreased, the Company was likely to cut its quarterly dividend and expand its cost reduction programs; and (5) as a result of the foregoing, positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Resideo Technologies, Inc. (NYSE:REZI)

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="REZI Lawsuit on behalf of: investors who purchased October 29, 2018 – October 22, 2019
Lead Plaintiff Deadline: January 7, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/resideo-technologies-inc-loss-form?prid=4694&wire=1” data-reactid=”19″>REZI Lawsuit on behalf of: investors who purchased October 29, 2018 – October 22, 2019
Lead Plaintiff Deadline: January 7, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/resideo-technologies-inc-loss-form?prid=4694&wire=1

According to the filed complaint, during the class period, Resideo Technologies, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) the negative operational effects of the Company’s spin-off from Honeywell International Inc. were more substantial and persistent than disclosed and had negatively affected Resideo’s product sales, supply chain, and gross margins, putting the Company’s FY19 financial forecasts at risk; and (b) as a result of the foregoing, the Company’s financial guidance lacked a reasonable basis and the Company was not on track to make its FY19 guidance as claimed.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.” data-reactid=”21″>You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
[email protected]
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com” data-reactid=”24″>Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
[email protected]
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com